Oncostatin M is a novel biomarker for coronary artery disease – A possibility as a screening tool of silent myocardial ischemia for diabetes mellitus

Objective: Oncostatin M (OSM) is an inflammatory cytokine of the interleukin-6 family which plays a crucial role in the pathogenesis of atherosclerosis. Therefore, we tested our hypothesis that serum OSM levels are increased in patients with coronary artery diseases (CAD). Methods and results: Serum...

Full description

Bibliographic Details

Published in:	International Journal of Cardiology: Heart & Vasculature
Main Authors:	Shohei Ikeda, Koichi Sato, Morihiko Takeda, Keita Miki, Kentaro Aizawa, Tsuyoshi Takada, Koji Fukuda, Nobuyuki Shiba
Format:	Article
Language:	English
Published:	Elsevier 2021-08-01
Subjects:	OSM Coronary artery diseases Silent myocardial ischemia Biomarker Diabetes mellitus
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352906721001172